Literature DB >> 6648808

Familial pheochromocytoma.

G L Irvin, L M Fishman, J A Sher.   

Abstract

During a 15-year period, 24 patients were treated operatively for pheochromocytoma at this medical center. In this group a father and three daughters were recognized to have the familial variety of this disease. Malignant hypertension, which began at an early age, was the most prominent characteristic. Operative treatment of the three sisters occurred at the ages of 9, 15, and 17 years. All pheochromocytomas were bilateral and were confined to the adrenal glands except for hepatic extension in the father. In contrast to most recent reports of familial pheochromocytoma, there was no evidence of multiple endocrine adenomatosis in this family. Total adrenalectomy was performed in only the youngest patient and, although normotensive, she requires close observation and steroid replacement. Three patients underwent a controversial partial adrenalectomy after excision of bilateral tumors. The father has remained hypertensive for 8 years and has evidence of a residual tumor in the liver. The two daughters who have had subtotal adrenalectomies remain normotensive, require no medication, and have normal urine catecholamine values 7 and 3 years after operation. These results show that removal of bilateral pheochromocytomas without total adrenalectomy may allow normal adrenal function free of recurrence for several years in patients without multiple endocrine adenomatosis.

Entities:  

Mesh:

Year:  1983        PMID: 6648808

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

1.  Minimally invasive cortical-sparing surgery for bilateral pheochromocytomas.

Authors:  Pier Francesco Alesina; Jakob Hinrichs; Beate Meier; Kurt W Schmid; Hartmut P H Neumann; Martin K Walz
Journal:  Langenbecks Arch Surg       Date:  2011-09-21       Impact factor: 3.445

2.  Case report of metastatic familial pheochromocytoma treated with cisplatin and 5-fluorouracil.

Authors:  V Srimuninnimit; G L Wampler
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 3.  Adrenal-preserving minimally invasive surgery: update on the current status of laparoscopic partial adrenalectomy.

Authors:  Grant I S Disick; Ravi Munver
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

4.  Robotic approach for partial adrenalectomy.

Authors:  Benedetto Calì; Claire Nomine-Criqui; Florence Bihain; Laurent Brunaud
Journal:  Updates Surg       Date:  2021-01-07

5.  Retroperitoneal adrenal-sparing surgery for the treatment of Cushing's syndrome caused by adrenocortical adenoma: 8-year experience with 87 patients.

Authors:  Hong-chao He; Jun Dai; Zhou-jun Shen; Yu Zhu; Fu-kang Sun; Yuan Shao; Rong-ming Zhang; Hao-fei Wang; Wen-bin Rui; Shan Zhong
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

6.  Adrenalectomy for familial pheochromocytoma in the laparoscopic era.

Authors:  L Michael Brunt; Terry C Lairmore; Gerard M Doherty; Mary A Quasebarth; Mary DeBenedetti; Jeffrey F Moley
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

7.  Pheochromocytoma. Lateral versus anterior operative approach.

Authors:  G L Irvin; L M Fishman; J A Sher; L K Yeung; H Irani
Journal:  Ann Surg       Date:  1989-06       Impact factor: 12.969

Review 8.  [Recurrent operations on the adrenal glands].

Authors:  M Brauckhoff; H Dralle
Journal:  Chirurg       Date:  2005-03       Impact factor: 0.955

Review 9.  [Adrenalectomy for preservation of adrenocortical function. Indication and results].

Authors:  M K Walz
Journal:  Chirurg       Date:  2009-02       Impact factor: 0.955

Review 10.  Gastrointestinal and retroperitoneal manifestations of type 1 neurofibromatosis.

Authors:  Ursula Basile; Giuseppe Cavallaro; Andrea Polistena; Sandra Giustini; Gennaro Orlando; Dario Cotesta; Luigi Petramala; Claudio Letizia; Stefano Calvieri; Giorgio De Toma
Journal:  J Gastrointest Surg       Date:  2010-01       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.